BC
DCPH

Brinker Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Brinker Capital’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$205K Buy
+3,437
New +$184K 0.01% 898
2020
Q1 		– Sell
-3,348
Closed -$208K – 1004
2019
Q4 		$208K Buy
+3,348
New +$159K 0.01% 926

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Brinker Capital's DCPH Position: Q2 2020 in Review

Brinker Capital opened a new position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2020: 3,437 shares worth $205K. The stake represents 0.01% of the portfolio and ranks #898 among its holdings. This is a return to the name: Brinker Capital previously reported a position in DCPH as recently as Q4 2019.

Brinker Capital first reported a position in DCPH in Q4 2019 and has held it in 2 quarters since. The position peaked at $208K in Q4 2019. 168 funds tracked by Wall St. Rank hold DCPH as of Q2 2020.

  • Brinker Capital held 3,437 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $205K as of Q2 2020.
  • Deciphera Pharmaceuticals, Inc. Common Stock was a new Brinker Capital position in Q2 2020.
  • Deciphera Pharmaceuticals, Inc. Common Stock made up 0.01% of Brinker Capital's portfolio in Q2 2020, its #898 holding.
  • Brinker Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and has held it in 2 quarters since.
  • Brinker Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $208K in Q4 2019.
  • 168 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.